Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

4.620

-0.030 (-0.65%)

At close: Apr 23, 2026

EGX:RMDA Income Statement

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,096	2,769	1,922	1,484	1,246
Revenue Growth (YoY)	47.94%	44.03%	29.54%	19.06%	29.81%
Cost of Revenue	2,114	1,485	1,018	765.28	669.61
Gross Profit	1,982	1,284	904.06	718.67	576.82
Selling, General & Admin	907.93	558.11	444.06	360.96	303.18
Other Operating Expenses	-8.98	-27.3	-7.34	-6.04	-0.76
Operating Expenses	1,020	558.54	458.3	376.41	302.53
Operating Income	962.45	725.44	445.76	342.26	274.29
Interest Expense	-531.27	-307.21	-191.2	-89.07	-91.03
Interest & Investment Income	18.81	65.85	62.9	56.73	59.97
Currency Exchange Gain (Loss)	-6.14	56.24	18.68	25.65	-0.6
Other Non Operating Income (Expenses)	-17.34	-11.7	-8.84	-6.99	-8.31
EBT Excluding Unusual Items	426.51	528.62	327.31	328.58	234.33
Gain (Loss) on Sale of Assets	0.15	0.01	0.14	-0.13	-0.72
Asset Writedown	-2.56	-2.51	-	-	-
Pretax Income	424.1	526.12	327.45	328.45	233.61
Income Tax Expense	110.89	124.31	74.24	75.57	53.52
Earnings From Continuing Operations	313.21	401.81	253.21	252.89	180.09
Minority Interest in Earnings	-14.75	-14.44	-8.35	-7.21	1
Net Income	298.46	387.37	244.86	245.68	181.09
Preferred Dividends & Other Adjustments	29.85	23.53	21.36	16.76	14.7
Net Income to Common	268.61	363.84	223.5	228.91	166.39
Net Income Growth	-22.95%	58.20%	-0.33%	35.67%	61.43%
Shares Outstanding (Basic)	2,000	2,002	1,973	1,952	2,015
Shares Outstanding (Diluted)	2,010	2,009	1,987	1,962	2,015
Shares Change (YoY)	0.02%	1.11%	1.27%	-2.62%	-
EPS (Basic)	0.13	0.18	0.11	0.12	0.08
EPS (Diluted)	0.13	0.18	0.11	0.12	0.08
EPS Growth	-26.23%	60.98%	-3.52%	41.22%	70.69%
Free Cash Flow	-199.57	-371.85	-135.54	-5.03	188.68
Free Cash Flow Per Share	-0.10	-0.18	-0.07	-0.00	0.09
Dividend Per Share	-	0.040	0.051	-	-
Dividend Growth	-	-20.71%	-	-	-
Gross Margin	48.39%	46.38%	47.03%	48.43%	46.28%
Operating Margin	23.50%	26.20%	23.19%	23.06%	22.01%
Profit Margin	6.56%	13.14%	11.63%	15.43%	13.35%
Free Cash Flow Margin	-4.87%	-13.43%	-7.05%	-0.34%	15.14%
EBITDA	1,046	804.84	514.61	403.67	316.61
EBITDA Margin	25.53%	29.07%	26.77%	27.20%	25.40%
D&A For EBITDA	83.39	79.4	68.85	61.41	42.31
EBIT	962.45	725.44	445.76	342.26	274.29
EBIT Margin	23.50%	26.20%	23.19%	23.06%	22.01%
Effective Tax Rate	26.15%	23.63%	22.67%	23.01%	22.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.